State WV
Clinical Trials in West Virginia
West Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in West Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 46 actively recruiting studies with West Virginia sites out of 46 registered in total. The busiest research areas in West Virginia are Chronic Migraine, Chronic Obstructive Pulmonary Disease (COPD), Stroke. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, West Virginia University. By stage, West Virginia trials break down as Phase 1 (1), Phase 2 (7), Phase 3 (14), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in West Virginia
Chronic Migraine (2)Chronic Obstructive Pulmonary Disease (COPD) (2)Stroke (2)Lumbar Spinal Stenosis (2)Complicated Intra-abdominal Infections (cIAI) (1)Lipoma (1)Advanced Malignant Solid Neoplasm (1)Anatomic Stage III Breast Cancer AJCC v8 (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)Locally Advanced Malignant Solid Neoplasm (1)Malignant Female Reproductive System Neoplasm (1)Metastatic HER2-Negative Breast Carcinoma (1)
Frequently Asked Questions — Clinical Trials in West Virginia
How many clinical trials are currently recruiting in West Virginia?
ClinicalMetric currently tracks 46 actively recruiting clinical trials with at least one location in West Virginia. The total number of registered studies—including active but not currently enrolling trials—is 46. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in West Virginia?
West Virginia hosts clinical trials across a broad range of medical conditions, including Chronic Migraine, Chronic Obstructive Pulmonary Disease (COPD), Stroke, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout West Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in West Virginia?
To join a clinical trial in West Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in West Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in West Virginia
NCT06794541 Phase 2
Recruiting
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Pat...
Condition
Complicated Intra-abdominal Infections (cIAI)
Enrollment
35 pts
Location
United States
Sponsor
Tetraphase Pharmaceuticals, In
NCT06820164 Phase 1, Phase 2
Recruiting
Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride
Condition
Lipoma
Enrollment
20 pts
Location
United States
Sponsor
West Virginia University
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,700 pts
Location
United States, Austria, Czechia
Sponsor
Bristol-Myers Squibb
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
NCT04638647 Phase 4
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
Condition
Autoimmunity, Inflammation
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06438315 N/A
Recruiting
SuperSaturated Oxygen Comprehensive Observational Registry
Condition
STEMI - ST Elevation Myocardial Infarction
Enrollment
1,000 pts
Location
United States
Sponsor
TherOx
NCT03619850 Phase 3
Recruiting
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmaco...
Condition
Chronic Kidney Disease; Iron Deficiency Anemia
Enrollment
129 pts
Location
United States, Hungary, Lithuania
Sponsor
AMAG Pharmaceuticals, Inc.
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
NCT06049420 N/A
Recruiting
Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rura...
Condition
Obesity
Enrollment
95 pts
Location
United States
Sponsor
West Virginia School of Osteop
NCT04967989 Phase 3
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Condition
Glaucoma and Ocular Hypertension
Enrollment
790 pts
Location
United States, Canada
Sponsor
University of Pittsburgh
NCT06479278 N/A
Recruiting
Talk With Me Baby to Enhance the Early Home Language Environment
Condition
Language Development
Enrollment
66 pts
Location
United States
Sponsor
IDeA States Pediatric Clinical
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, China
Sponsor
Boston Scientific Corporation
NCT03876054 N/A
Recruiting
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Condition
Chronic Pain
Enrollment
2,000 pts
Location
United States, Australia, Belgium
Sponsor
Abbott Medical Devices
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT06138405 N/A
Recruiting
Dental-Child Interaction Training
Condition
Behavior and Behavior Mechanisms
Enrollment
5,808 pts
Location
United States
Sponsor
University of Florida
NCT06883305 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participa...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
990 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07264634 N/A
Recruiting
A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating ...
Condition
Hypoparathyroidism
Enrollment
10 pts
Location
United States
Sponsor
Ascendis Pharma A/S
NCT06911632 N/A
Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring ...
Condition
Pulmonary Hypertension
Enrollment
900 pts
Location
United States
Sponsor
Tempus AI
NCT05204888 N/A
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Condition
COPD
Enrollment
642 pts
Location
United States, Canada
Sponsor
Temple University
Page 1 of 2 — 46 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology